Send the following on WhatsApp
Continue to ChatVenetoclax and obinutuzumab funded in England by NICE, acalabrutinib licensed- the end of FCR chemotherapy for CLL? https://bloodcanceruncensored.com/venetoclax-and-obinutuzumab-funded-in-england-by-nice-acalabrutinib-licensed-the-end-of-fcr-chemotherapy-for-cll/